INSMED INC's ticker is and the CUSIP is 457669AA7. A total of 35 filers reported holding INSMED INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $3,000 | -99.3% | 3,000 | -99.3% | 0.00% | – |
| Q1 2022 | $427,000 | +4170.0% | 428,000 | +4180.0% | 0.00% | – |
| Q4 2021 | $10,000 | -99.8% | 10,000 | -99.8% | 0.00% | -100.0% |
| Q3 2021 | $5,729,000 | -42.4% | 5,538,000 | -41.8% | 0.00% | 0.0% |
| Q2 2021 | $9,940,000 | -16.4% | 9,517,000 | -10.9% | 0.00% | 0.0% |
| Q1 2021 | $11,893,000 | +160.1% | 10,685,000 | +127.1% | 0.00% | 0.0% |
| Q2 2020 | $4,572,000 | +904.8% | 4,704,000 | +763.1% | 0.00% | – |
| Q1 2020 | $455,000 | -92.1% | 545,000 | -92.1% | 0.00% | -100.0% |
| Q3 2019 | $5,751,000 | +52181.8% | 6,900,000 | +62627.3% | 0.00% | – |
| Q1 2019 | $11,000 | -15.4% | 11,000 | -42.1% | 0.00% | – |
| Q4 2018 | $13,000 | -99.9% | 19,000 | -99.8% | 0.00% | -100.0% |
| Q3 2018 | $9,231,000 | +46.5% | 10,966,000 | +59.8% | 0.00% | 0.0% |
| Q2 2018 | $6,300,000 | +10.9% | 6,862,000 | +6.2% | 0.00% | 0.0% |
| Q1 2018 | $5,679,000 | – | 6,459,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sycale Advisors (NY) LLC | 8,065,000 | $9,173,000 | 6.54% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 61,000,000 | $69,219,000 | 1.37% |
| Sonora Investment Management, LLC | 6,645,000 | $7,519,000 | 0.62% |
| ZAZOVE ASSOCIATES LLC | 4,377,000 | $4,951,000 | 0.61% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 22,362,000 | $25,324,000 | 0.54% |
| SSI INVESTMENT MANAGEMENT LLC | 6,532,000 | $7,328,000 | 0.52% |
| Context Capital Management, LLC | 2,163,000 | $2,438,000 | 0.33% |
| WOLVERINE ASSET MANAGEMENT LLC | 35,070,000 | $39,493,000 | 0.29% |
| Cheyne Capital Management (UK) LLP | 450,000 | $509,000 | 0.26% |
| FARALLON CAPITAL MANAGEMENT LLC | 32,500,000 | $36,552,000 | 0.22% |